Frequently asked questions

Are the parallel import product and the original product* identical?
Yes, all parallel import products are from the manufacturer of the original products.

Are the products authorized by Swissmedic?
Yes, authorization is granted in accordance with Article 14, paragraphs 2 and 3 TPA (parallel import). In addition, parallel import products are subject to the same GDP guidelines (2013/C 343/01) as all medicinal products authorized in Switzerland.

Are the costs of the products covered by health insurance?
Yes, the products included in the specialty list are reimbursed by compulsory health insurance. TParallel import products are considerably cheaper than the corresponding original products*.

Do parallel import products have advantages compared to original products*?
Yes, parallel import products help to save costs in the Swiss healthcare system. This not only relieves the burden on the healthcare system, but also reduces costs for patients.

* Original products, biosimilars and generics